Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $343.78 +3.27%
Financial Fact:
Interest expense: 5.63M
Today's EPS Names:
GLXY, CRVL, SGHC, More
Financial Fact:
Interest expense: 5.63M
Today's EPS Names:
GLXY, CRVL, SGHC, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carlyle sees improving exit conditions for "good companies"
- Immuneering Corporation (IMRX) Reports In-Line Q2 EPS
- BioNTech SE (BNTX) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
